Compare ProShares Ultra Silver ETF (AGQ) vs BridgeBio Pharma Inc (BBIO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ProShares Ultra Silver ETF vs BridgeBio Pharma Inc — how do they compare? ProShares Ultra Silver ETF trades at $83, while BridgeBio Pharma Inc trades at $83.86 (market cap $16.36B). The key difference: BridgeBio Pharma Inc is trading nearer its 52-week high, ProShares Ultra Silver ETF nearer its low. Which is the better fit depends on your goals.
| AGQ | BBIO | |
|---|---|---|
Sector | Leveraged / Inverse | Health |
52-Week High | $400.47 | $90.17 |
52-Week Low | $49.73 | $47.29 |
Market Cap | — | $16.36B |
Enterprise Value | — | $18.14B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ProShares Ultra Silver ETF
AGQ is a leveraged ETF that seeks daily investment results corresponding to two times (2x) the daily performance of silver bullion. It is designed for investors seeking magnified short-term exposure to silver prices.
Read more on AGQ →About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →
